Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HlV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity.
Saved in:
| Title: | Combination Therapy with Amprenavir, Abacavir, and Efavirenz in Human Immunodeficiency Virus (HlV)-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity. |
|---|---|
| Authors: | Falloon, Judith, Piscitelli, Stephen, Vogel, Susan, Sadler, Brian, Mitsuya, Hiroaki, Kavlick, Mark F., Yoshimura, Kazuhisa, Rogers, Michael, LaFon, Steven, Manion, Douglas J., Lane, H. Clifford, Masur, Henry |
| Source: | Clinical Infectious Diseases. 2/1/2000, Vol. 30 Issue 2, p313-318. 6p. |
| Database: | Environment Complete |
Be the first to leave a comment!
